PARIS, October 30 /PRNewswire/ --

Key Highlights for the Quarter - Revenues of Euro 4.065 Billion, Down 0.9% Sequentially - Adjusted(2) Gross Profit of Euro 1.320 Billion or 32.5% of Revenues (33.0% excl. one time item) - Adjusted(2) Operating Income(1) of Euro 40 Million or 1.0% of Revenues - Adjusted(2) Net Income (Group Share) of Euro 41 Million or Euro 0.02 per Diluted Share - Reported Net Loss (Group Share) of Euro (40) Million or Euro (0.02) per Diluted Share - Net Debt of Euro 600 Million at September 30, 2008 - Funded Status of Pensions and OPEB Shows Surplus of Euro 2.997 Billion at September 30, 2008

TORONTO, October 30 /PRNewswire/ --

- US Operators Can Now Utilize Rural Broadband Funding to Deploy Redline's RedMAX(TM) and RedCONNEX(TM) Products

Redline Communications Group Inc. (Redline) (TSX and AIM: RDL), a leading provider of WiMAX and broadband wireless infrastructure products, today announced that it has received USDA acceptance and Buy American status from the U.S. Department of Agriculture Rural Utility Services (RUS) for its RedMAX and RedCONNEX products. The acceptance will enable network operators in the United States to take advantage of a federal rural broadband funding program when deploying Redline's broadband wireless products in support of rural residential, business and community wireless services.

PARIS, October 30 /PRNewswire/ --

Key Highlights for the Quarter - Revenues of Euro 4.065 Billion, Down 0.9% Sequentially - Adjusted(2) Gross Profit of Euro 1.320 Billion or 32.5% of Revenues (33.0% excl. one time item) - Adjusted(2) Operating Income(1) of Euro 40 Million or 1.0% of Revenues - Adjusted(2) Net Income (Group Share) of Euro 41 Million or Euro 0.02 per Diluted Share - Reported Net Loss (Group Share) of Euro (40) Million or Euro (0.02) per Diluted Share - Net Debt of Euro 600 Million at September 30, 2008 - Funded Status of Pensions and OPEB Shows Surplus of Euro 2.997 Billion at September 30, 2008

COPENHAGEN, Denmark, October 29 /PRNewswire/ --

- Summary: Genmab Reports Results for the Nine Month Period Ended September 30, 2008

Genmab A/S (OMX: GEN) announced today results for the nine month period ended September 30, 2008. During this period, Genmab reported the following results:

- Genmab's revenues were DKK 667 million (USD 128 million) for the nine month period ended September 30, 2008. In the same period of 2007, Genmab recognized revenues of DKK 356 million (USD 68 million).

MOUNTAIN VIEW, California, October 29 /PRNewswire/ --

Bytemobile, Inc., the global leader in mobile internet solutions for network operators, today announced the opening of a new center for both research and development and customer support services in Belfast, Northern Ireland. The company established the facility under an agreement with Invest Northern Ireland (NI), which attracts new investment to the country.

SAN MATEO, California, October 29 /PRNewswire/ --

NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will report results for its third quarter 2008 on Thursday, November 6, 2008, after the market closes.

A conference call to review the results and discuss corporate and clinical initiatives for the remainder of 2008 and into 2009 will begin at 4:30 p.m. ET (1:30 p.m. PT) on November 6, 2008 and will be hosted by Anthony DiTonno, President and Chief Executive Officer, and Stephen Ghiglieri, Chief Financial Officer.